Literature DB >> 33526140

Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution.

Kevin F Boehnke1, Evangelos Litinas2, Brianna Worthing2, Lisa Conine2, Daniel J Kruger3.   

Abstract

BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established treatment options.
METHODS: We conducted an anonymous, cross-sectional online survey among patrons of a medical cannabis dispensary in Michigan (n = 275) to examine aspects of their relationship with their PCP and their perceptions of PCP knowledge related to cannabis.
RESULTS: Overall, 64% of participants initiated medical cannabis use based on their own experiences vs. 24% citing advice from their PCP. Although 80% reported that their PCP knew they currently used medical cannabis, 41% reported that their PCP had not always known. Only 14% obtained their medical cannabis authorization from their PCP. Only 18% of participants rated their PCP's knowledge about medical cannabis as very good or excellent and only 21% were very or completely confident in their PCP's ability to integrate medical cannabis into their treatment. Although 86% had substituted cannabis for pharmaceutical medications, 69% (n = 134) of those who substituted reported some gap in their PCP's knowledge of their substitution, and 44% (n = 86) reported that their PCP was currently unaware of their substitution.
CONCLUSIONS: Patients frequently substitute cannabis for prescription drugs, often without PCP knowledge. Although most participants disclosed cannabis use to their PCP, their perceptions of PCP knowledge ranged widely and many obtained medical cannabis licensure from an outside physician. Our results highlight the need for standardized physician education around appropriate medical cannabis use.

Entities:  

Keywords:  Healthcare provider knowledge; Medical cannabis; Medical cannabis referral; Medication substitution

Year:  2021        PMID: 33526140      PMCID: PMC7831240          DOI: 10.1186/s42238-021-00058-0

Source DB:  PubMed          Journal:  J Cannabis Res        ISSN: 2522-5782


  6 in total

1.  Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey.

Authors:  Mike Armour; Justin Sinclair; Junipearl Cheng; Preston Davis; Aaish Hameed; Harini Meegahapola; Krithika Rajashekar; Sunethra Suresh; Andrew Proudfoot; Mathew Leonardi
Journal:  Cannabis Cannabinoid Res       Date:  2022-01-28

2.  Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.

Authors:  Justin Sinclair; Yasmine Toufaili; Sarah Gock; Amanda G Pegorer; Jordan Wattle; Martin Franke; Muayed A K M Alzwayid; Jason Abbott; David W Pate; Jerome Sarris; Mike Armour
Journal:  Cannabis Cannabinoid Res       Date:  2021-12-31

Review 3.  Cannabis for Rheumatic Disease Pain: a Review of Current Literature.

Authors:  William Benjamin Nowell; Kelly Gavigan; Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2022-04-29       Impact factor: 4.686

4.  Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context.

Authors:  Alexis Holman; Daniel J Kruger; Philippe Lucas; Kaye Ong; Rachel S Bergmans; Kevin F Boehnke
Journal:  J Cannabis Res       Date:  2022-06-13

5.  Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.

Authors:  Gwen T Lapham; Theresa E Matson; David S Carrell; Jennifer F Bobb; Casey Luce; Malia M Oliver; Udi E Ghitza; Clarissa Hsu; Kendall C Browne; Ingrid A Binswanger; Cynthia I Campbell; Andrew J Saxon; Ryan Vandrey; Gillian L Schauer; Rosalie Liccardo Pacula; Michael A Horberg; Steffani R Bailey; Erin A McClure; Katharine A Bradley
Journal:  JAMA Netw Open       Date:  2022-05-02

6.  Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain.

Authors:  Marimée Godbout-Parent; Hermine Lore Nguena Nguefack; Adriana Angarita-Fonseca; Claudie Audet; Andréanne Bernier; Ghita Zahlan; Nancy Julien; M Gabrielle Pagé; Line Guénette; Lucie Blais; Anaïs Lacasse
Journal:  Can J Pain       Date:  2022-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.